These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1707043)

  • 1. Tissue distribution of 99mTc, 111In and 123I-OV-TL 3 Fab' in ovarian carcinoma bearing nude mice.
    Massuger LF; Claessens RA; Pak KY; Boerman OC; Daddona PE; Koenders EB; Kenemans P; Corstens FH
    Int J Rad Appl Instrum B; 1991; 18(1):77-83. PubMed ID: 1707043
    [No Abstract]   [Full Text] [Related]  

  • 2. Biodistribution of iodine-125 and indium-111 labeled OV-TL 3 intact antibodies and F(ab')2 fragments in tumor-bearing athymic mice.
    Massuger LF; Boerman OC; Corstens FH; Verheijen RH; Claessens RA; Poels LG; van den Broek WJ; Kenemans P
    Anticancer Res; 1991; 11(6):2051-7. PubMed ID: 1776839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the pharmacokinetics, biodistribution and dosimetry of monoclonal antibodies OC125, OV-TL 3, and 139H2 as IgG and F(ab')2 fragments in experimental ovarian cancer.
    Molthoff CF; Pinedo HM; Schlüper HM; Nijman HW; Boven E
    Br J Cancer; 1992 May; 65(5):677-83. PubMed ID: 1586596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo targeting of OV-TL 3 immunoliposomes to ascitic ovarian carcinoma cells (OVCAR-3) in athymic nude mice.
    Nässander UK; Steerenberg PA; Poppe H; Storm G; Poels LG; De Jong WH; Crommelin DJ
    Cancer Res; 1992 Feb; 52(3):646-53. PubMed ID: 1732053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A human/mouse chimeric monoclonal antibody against CA125 for radioimmunoimaging of ovarian cancer.
    Kobayashi H; Sakahara H; Saga T; Hosono M; Shirato M; Kanda H; Ishibashi K; Watanabe T; Endo K; Ishiwata I
    Cancer Immunol Immunother; 1993 Aug; 37(3):143-9. PubMed ID: 7687520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging of human ovarian tumour xenografts in nude mice using a novel 111In-labelled monoclonal antibody (10B).
    Sheldon K; Reilly R; Baumal R; Marks A
    Int J Rad Appl Instrum B; 1991; 18(5):519-26. PubMed ID: 1917522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro binding characteristics and biodistribution in tumor-bearing athymic mice of anti-ovarian carcinoma monoclonal antibodies.
    Boerman O; Massuger L; Makkink K; Thomas C; Kenemans P; Poels L
    Anticancer Res; 1990; 10(5A):1289-95. PubMed ID: 2241105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of cleavable and noncleavable hydrazinopyridine linkers for the 99mTc labeling of Fab' monoclonal antibody fragments.
    Bridger GJ; Abrams MJ; Padmanabhan S; Gaul F; Larsen S; Henson GW; Schwartz DA; Longley CB; Burton CA; Ultee ME
    Bioconjug Chem; 1996; 7(2):255-64. PubMed ID: 8983348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic evaluation of 111In and 99mTc radiolabelled monoclonal antibodies in ovarian and colorectal cancer: correlations with surgery.
    Granowska M; Mather SJ; Britton KE
    Int J Rad Appl Instrum B; 1991; 18(4):413-24. PubMed ID: 1864730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioimaging of human ovarian carcinoma xenograft in nude mice.
    Manetta A; Satyaswaroop PG; Hamilton T; Ozols R; Mortel R
    Gynecol Oncol; 1987 Nov; 28(3):292-9. PubMed ID: 3678978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral anti-OV-TL 3 response after the intravenous administration of radiolabelled Fab' or F(ab')2 fragments in ovarian cancer patients.
    Tibben JG; Thomas CM; Massuger LF; Segers MF; Schijf CP; Corstens FH; Boerman OC
    Nucl Med Commun; 1995 Oct; 16(10):853-9. PubMed ID: 8570116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics, biodistribution, and gamma camera imaging of 111In-KC-4G3 murine monoclonal antibody in athymic nude mice with or without human tumor xenografts.
    Longley C; Furmanski P; Dienhart DG; Lear J; Bloedow D; Kasliwal R; Bunn PA
    Cancer Res; 1990 Sep; 50(18):5954-61. PubMed ID: 2393864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of tumor-related factors of influence on the uptake of the monoclonal antibody 323/A3 in experimental human ovarian cancer.
    Kievit E; Pinedo HM; Schlüper HM; Haisma HJ; Boven E
    Int J Cancer; 1997 Apr; 71(2):237-45. PubMed ID: 9139849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioimmunoscintigraphy of xenografted human thyroid carcinoma.
    Koizumi K; Yokoyama K; Watanabe N; Kawabata S; Shuke N; Kinuya S; Aburano T; Tonami N; Hisada K; Sato N
    Ann Nucl Med; 1988 May; 2(1):21-5. PubMed ID: 3275101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-clinical evaluation of [111In]-benzyl-DOTA-Z(HER2:342), a potential agent for imaging of HER2 expression in malignant tumors.
    Orlova A; Tran T; Widström C; Engfeldt T; Eriksson Karlström A; Tolmachev V
    Int J Mol Med; 2007 Sep; 20(3):397-404. PubMed ID: 17671747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biodistribution, pharmacokinetics and imaging of 131I-labeled HMD4 human McAb in human ovarian carcinoma xenograft in nude mice].
    Cui H
    Zhonghua Fu Chan Ke Za Zhi; 1990 Mar; 25(2):80-3, 123. PubMed ID: 2364795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo biodistribution of a humanized anti-Lewis Y monoclonal antibody (hu3S193) in MCF-7 xenografted BALB/c nude mice.
    Clarke K; Lee FT; Brechbiel MW; Smyth FE; Old LJ; Scott AM
    Cancer Res; 2000 Sep; 60(17):4804-11. PubMed ID: 10987290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of colorectal tumor targeting using a novel biparatopic monoclonal antibody against carcinoembryonic antigen in experimental radioimmunoguided surgery.
    Kim JC; Roh SA; Koo KH; Ryu JH; Hong HK; Oh SJ; Ryu JS; Kim HJ; Bodmer WF
    Int J Cancer; 2002 Feb; 97(4):542-7. PubMed ID: 11802220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the biodistribution and the efficacy of monoclonal antibody 323/A3 labeled with either 131I or 186Re in human ovarian cancer xenografts.
    Kievit E; van Gog FB; Schlüper HM; van Dongen GA; Pinedo HM; Boven E
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):813-23. PubMed ID: 9240651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biokinetics of the monoclonal antibodies MOv 18, OV 185 and OV 197 labelled with 125I according to the m-MeATE method or the Iodogen method in nude mice with ovarian cancer xenografts.
    Andersson H; Lindegren S; Bäck T; Jacobsson L; Leser G; Horvath G
    Acta Oncol; 1999; 38(3):323-8. PubMed ID: 10380823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.